A detailed history of Boston Family Office LLC transactions in Amgen Inc stock. As of the latest transaction made, Boston Family Office LLC holds 8,364 shares of AMGN stock, worth $2.21 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
8,364
Previous 8,416 0.62%
Holding current value
$2.21 Million
Previous $2.63 Million 2.47%
% of portfolio
0.18%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $16,087 - $17,543
-52 Reduced 0.62%
8,364 $2.7 Million
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $13,663 - $16,604
-52 Reduced 0.61%
8,416 $2.63 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $12,636 - $15,254
-47 Reduced 0.55%
8,468 $2.41 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $21,478 - $24,230
-84 Reduced 0.98%
8,515 $2.45 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $26,019 - $32,303
119 Added 1.4%
8,599 $2.31 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $16,713 - $19,762
78 Added 0.93%
8,480 $1.88 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $31,610 - $38,528
-140 Reduced 1.64%
8,402 $2.03 Million
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $63,899 - $81,191
-279 Reduced 3.16%
8,542 $2.24 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $129,962 - $146,573
-579 Reduced 6.16%
8,821 $1.99 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $27,685 - $30,808
-120 Reduced 1.26%
9,400 $2.29 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $40,564 - $44,875
185 Added 1.98%
9,520 $2.3 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $10,142 - $11,607
51 Added 0.55%
9,335 $2.1 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $2,122 - $2,487
-10 Reduced 0.11%
9,284 $1.97 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $223,463 - $260,410
-1,007 Reduced 9.78%
9,294 $2.37 Million
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $93,390 - $103,858
-398 Reduced 3.72%
10,301 $2.62 Million
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $44,507 - $54,616
-225 Reduced 2.06%
10,699 $2.52 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $54,489 - $72,268
299 Added 2.81%
10,924 $2.22 Million
Q4 2019

Feb 05, 2020

SELL
$189.21 - $243.2 $17,596 - $22,617
-93 Reduced 0.87%
10,625 $2.56 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $17,759 - $21,279
102 Added 0.96%
10,718 $2.07 Million
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $4,167 - $4,885
-25 Reduced 0.23%
10,616 $1.96 Million
Q1 2019

May 09, 2019

SELL
$180.87 - $203.88 $3,617 - $4,077
-20 Reduced 0.19%
10,641 $2.02 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $8,206 - $9,579
46 Added 0.43%
10,661 $2.08 Million
Q3 2018

Nov 01, 2018

SELL
$185.29 - $208.89 $29,646 - $33,422
-160 Reduced 1.48%
10,615 $2.2 Million
Q2 2018

Jul 26, 2018

SELL
$166.05 - $186.51 $65,589 - $73,671
-395 Reduced 3.54%
10,775 $1.99 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $127,919 - $149,490
-755 Reduced 6.33%
11,170 $1.9 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $12,659 - $14,144
-75 Reduced 0.63%
11,925 $2.07 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $2.01 Million - $2.29 Million
12,000
12,000 $2.24 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.